As part of our mission, we are committed to innovation and advancement of the field of Neuroscience to improve the care of our patients now and in the future. Our research program spans across important diseases that afflict our patients that we see each day. We have both translational and clinical research studies ongoing that are receiving regional, national and international attention. Our research programs are tightly coupled with the clinical interests of our faculty.

Our cerebrovascular research program aims to investigate mechanisms underlying cerebral aneurysm formation, progression and rupture with the ultimate goal of translating this knowledge to develop minimally or non-invasive therapies for our patients harboring these potentially devastating lesions. In the laboratory of Dr. Aaron Dumont, our team uses both in vitro and in vivo models for this line of research. Exciting emerging data from our laboratory demonstrates strategies to prevent aneurysm formation, growth and rupture.

Our clinical research program is multifaceted and includes epidemiological research (on brain aneurysms, intracerebral hemorrhage, other forms of stroke and spine disorders), clinical trials of endovascular devices (for stroke and cerebrovascular disorders), medical and surgical therapies for stroke, spine and movement disorders, and patient outcome-based research for patients with neurosurgical diseases.

Our Department encourages collaboration throughout our institution. The neurosurgery and neurology teams at Tulane Doctors Neurosciences work with the Tulane Brain Institute, a University-wide Brain Institute that was created as a transdisciplinary entity to coordinate and oversee neuroscience-related endeavors at Tulane and bring together faculty from across the University’s numerous campuses. We also have strong relationships with the Department of Pharmacology and Physiology as well as with the School of Public Health and Tropical Medicine. We also have research collaborations across the United States and internationally.